APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Non-opioid Topical Pain Relief

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Non-opioid Topical Pain Relief Industry Growth and Trends Forecast to 2032

Report ID 174017700122 December 2025118 pages

Choose your research edition.

Industry ResearchNon-opioid Topical Pain Relief Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-opioid Topical Pain Relief Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Non-opioid Topical Pain Relief Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-opioid Topical Pain Relief Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-opioid Topical Pain Relief Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Non-opioid Topical Pain Relief market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Non-opioid Topical Pain Relief is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Non-opioid Topical Pain Relief is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-opioid Topical Pain Relief is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-opioid Topical Pain Relief include Teva Pharmaceutical, Sanofi, Johnson and Johnson, Mylan, Pfizer, GlaxoSmithKline, Topical BioMedics, Tibet Cheezheng Tibetan Medicine and Sun Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Non-opioid Topical Pain Relief market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Non-opioid Topical Pain Relief market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-opioid Topical Pain Relief market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-opioid Topical Pain Relief.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Non-opioid Topical Pain Relief market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Non-opioid Topical Pain Relief Market by Company

Teva Pharmaceutical

Sanofi

Johnson and Johnson

Mylan

Pfizer

GlaxoSmithKline

Topical BioMedics

Tibet Cheezheng Tibetan Medicine

Sun Pharmaceutical Industries

Reckitt Benckiser Group

Lingrui Pharmaceutical

Hisamitsu

China Resources Sanjiu Medical & Pharmaceutical

AdvaCare Pharma

Abacus Health Products

Non-opioid Topical Pain Relief Segment by Type

Prescription Pain Relief

Over-The-Counter Pain Relief

Non-opioid Topical Pain Relief Segment by Application

Clinic

Hospital

Pharmacy

Others

Non-opioid Topical Pain Relief Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-opioid Topical Pain Relief market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-opioid Topical Pain Relief and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-opioid Topical Pain Relief.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-opioid Topical Pain Relief manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Non-opioid Topical Pain Relief in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Prescription Pain Relief Table 2. Major Company of Over-The-Counter Pain Relief Table 3. Global Non-opioid Topical Pain Relief Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (k units) Table 5. Global Non-opioid Topical Pain Relief Sales Market Share in Volume by Type (2021-2026) Table 6. Global Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (US$ Million) Table 7. Global Non-opioid Topical Pain Relief Sales Market Share in Value by Type (2021-2026) Table 8. Global Non-opioid Topical Pain Relief Price by Type (2021-2026) & (US$/unit) Table 9. Global Non-opioid Topical Pain Relief Sales by Type (2027-2032) & (k units) Table 10. Global Non-opioid Topical Pain Relief Sales Market Share in Volume by Type (2027-2032) Table 11. Global Non-opioid Topical Pain Relief Sales by Type (2027-2032) & (US$ Million) Table 12. Global Non-opioid Topical Pain Relief Sales Market Share in Value by Type (2027-2032) Table 13. Global Non-opioid Topical Pain Relief Price by Type (2027-2032) & (US$/unit) Table 14. North America Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (k units) Table 15. North America Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (k units) Table 17. Europe Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (k units) Table 21. Latin America Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (US$ Million) Table 24. Non-opioid Topical Pain Relief Industry Trends Table 25. Non-opioid Topical Pain Relief Industry Drivers Table 26. Non-opioid Topical Pain Relief Industry Opportunities and Challenges Table 27. Non-opioid Topical Pain Relief Industry Restraints Table 28. Global Non-opioid Topical Pain Relief Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Non-opioid Topical Pain Relief Revenue Market Share by Company (2021-2026) Table 30. Global Non-opioid Topical Pain Relief Sales by Company (2021-2026) & (k units) Table 31. Global Non-opioid Topical Pain Relief Sales Share by Company (2021-2026) Table 32. Global Non-opioid Topical Pain Relief Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Non-opioid Topical Pain Relief Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Non-opioid Topical Pain Relief Major Company Production Sites and Headquarters Table 35. Global Non-opioid Topical Pain Relief Company, Product Type & Application Table 36. Global Non-opioid Topical Pain Relief Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Non-opioid Topical Pain Relief by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Non-opioid Topical Pain Relief Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Non-opioid Topical Pain Relief Sales by Region (2021-2026) & (k units) Table 41. Global Non-opioid Topical Pain Relief Sales Market Share in Volume by Region (2021-2026) Table 42. Global Non-opioid Topical Pain Relief Sales by Region (2021-2026) & (US$ Million) Table 43. Global Non-opioid Topical Pain Relief Sales Market Share in Value by Region (2021-2026) Table 44. Global Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Non-opioid Topical Pain Relief Sales by Region (2027-2032) & (k units) Table 46. Global Non-opioid Topical Pain Relief Sales Market Share in Volume by Region (2027-2032) Table 47. Global Non-opioid Topical Pain Relief Sales by Region (2027-2032) & (US$ Million) Table 48. Global Non-opioid Topical Pain Relief Sales Market Share in Value by Region (2027-2032) Table 49. Global Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Non-opioid Topical Pain Relief Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (k units) Table 52. Global Non-opioid Topical Pain Relief Sales Market Share in Volume by Application (2021-2026) Table 53. Global Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (US$ Million) Table 54. Global Non-opioid Topical Pain Relief Sales Market Share in Value by Application (2021-2026) Table 55. Global Non-opioid Topical Pain Relief Price by Application (2021-2026) & (US$/unit) Table 56. Global Non-opioid Topical Pain Relief Sales by Application (2027-2032) & (k units) Table 57. Global Non-opioid Topical Pain Relief Sales Market Share in Volume by Application (2027-2032) Table 58. Global Non-opioid Topical Pain Relief Sales by Application (2027-2032) & (US$ Million) Table 59. Global Non-opioid Topical Pain Relief Sales Market Share in Value by Application (2027-2032) Table 60. Global Non-opioid Topical Pain Relief Price by Application (2027-2032) & (US$/unit) Table 61. North America Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (k units) Table 62. North America Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (k units) Table 64. Europe Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (k units) Table 68. Latin America Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Pharmaceutical Company Information Table 72. Teva Pharmaceutical Business Overview Table 73. Teva Pharmaceutical Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Teva Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio Table 75. Teva Pharmaceutical Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sanofi Non-opioid Topical Pain Relief Product Portfolio Table 80. Sanofi Recent Development Table 81. Johnson and Johnson Company Information Table 82. Johnson and Johnson Business Overview Table 83. Johnson and Johnson Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Johnson and Johnson Non-opioid Topical Pain Relief Product Portfolio Table 85. Johnson and Johnson Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Mylan Non-opioid Topical Pain Relief Product Portfolio Table 90. Mylan Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Pfizer Non-opioid Topical Pain Relief Product Portfolio Table 95. Pfizer Recent Development Table 96. GlaxoSmithKline Company Information Table 97. GlaxoSmithKline Business Overview Table 98. GlaxoSmithKline Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. GlaxoSmithKline Non-opioid Topical Pain Relief Product Portfolio Table 100. GlaxoSmithKline Recent Development Table 101. Topical BioMedics Company Information Table 102. Topical BioMedics Business Overview Table 103. Topical BioMedics Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Topical BioMedics Non-opioid Topical Pain Relief Product Portfolio Table 105. Topical BioMedics Recent Development Table 106. Tibet Cheezheng Tibetan Medicine Company Information Table 107. Tibet Cheezheng Tibetan Medicine Business Overview Table 108. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product Portfolio Table 110. Tibet Cheezheng Tibetan Medicine Recent Development Table 111. Sun Pharmaceutical Industries Company Information Table 112. Sun Pharmaceutical Industries Business Overview Table 113. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product Portfolio Table 115. Sun Pharmaceutical Industries Recent Development Table 116. Reckitt Benckiser Group Company Information Table 117. Reckitt Benckiser Group Business Overview Table 118. Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Reckitt Benckiser Group Non-opioid Topical Pain Relief Product Portfolio Table 120. Reckitt Benckiser Group Recent Development Table 121. Lingrui Pharmaceutical Company Information Table 122. Lingrui Pharmaceutical Business Overview Table 123. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio Table 125. Lingrui Pharmaceutical Recent Development Table 126. Hisamitsu Company Information Table 127. Hisamitsu Business Overview Table 128. Hisamitsu Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Hisamitsu Non-opioid Topical Pain Relief Product Portfolio Table 130. Hisamitsu Recent Development Table 131. China Resources Sanjiu Medical & Pharmaceutical Company Information Table 132. China Resources Sanjiu Medical & Pharmaceutical Business Overview Table 133. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio Table 135. China Resources Sanjiu Medical & Pharmaceutical Recent Development Table 136. AdvaCare Pharma Company Information Table 137. AdvaCare Pharma Business Overview Table 138. AdvaCare Pharma Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. AdvaCare Pharma Non-opioid Topical Pain Relief Product Portfolio Table 140. AdvaCare Pharma Recent Development Table 141. Abacus Health Products Company Information Table 142. Abacus Health Products Business Overview Table 143. Abacus Health Products Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Abacus Health Products Non-opioid Topical Pain Relief Product Portfolio Table 145. Abacus Health Products Recent Development Table 146. North America Non-opioid Topical Pain Relief Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. North America Non-opioid Topical Pain Relief Sales by Country (2021-2026) & (k units) Table 148. North America Non-opioid Topical Pain Relief Sales Market Share by Country (2021-2026) Table 149. North America Non-opioid Topical Pain Relief Sales Forecast by Country (2027-2032) & (k units) Table 150. North America Non-opioid Topical Pain Relief Sales Market Share Forecast by Country (2027-2032) Table 151. North America Non-opioid Topical Pain Relief Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Non-opioid Topical Pain Relief Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Non-opioid Topical Pain Relief Market Share by Country (2021-2026) Table 154. North America Non-opioid Topical Pain Relief Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Non-opioid Topical Pain Relief Market Share Forecast by Country (2027-2032) Table 156. Europe Non-opioid Topical Pain Relief Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Europe Non-opioid Topical Pain Relief Sales by Country (2021-2026) & (k units) Table 158. Europe Non-opioid Topical Pain Relief Sales Market Share by Country (2021-2026) Table 159. Europe Non-opioid Topical Pain Relief Sales Forecast by Country (2027-2032) & (k units) Table 160. Europe Non-opioid Topical Pain Relief Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Non-opioid Topical Pain Relief Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Non-opioid Topical Pain Relief Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Non-opioid Topical Pain Relief Market Share by Country (2021-2026) Table 164. Europe Non-opioid Topical Pain Relief Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Non-opioid Topical Pain Relief Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Non-opioid Topical Pain Relief Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Non-opioid Topical Pain Relief Sales by Country (2021-2026) & (k units) Table 168. Asia-Pacific Non-opioid Topical Pain Relief Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Non-opioid Topical Pain Relief Sales Forecast by Country (2027-2032) & (k units) Table 170. Asia-Pacific Non-opioid Topical Pain Relief Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Non-opioid Topical Pain Relief Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Non-opioid Topical Pain Relief Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Non-opioid Topical Pain Relief Market Share by Country (2021-2026) Table 174. Asia-Pacific Non-opioid Topical Pain Relief Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Non-opioid Topical Pain Relief Market Share Forecast by Country (2027-2032) Table 176. Latin America Non-opioid Topical Pain Relief Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Latin America Non-opioid Topical Pain Relief Sales by Country (2021-2026) & (k units) Table 178. Latin America Non-opioid Topical Pain Relief Sales Market Share by Country (2021-2026) Table 179. Latin America Non-opioid Topical Pain Relief Sales Forecast by Country (2027-2032) & (k units) Table 180. Latin America Non-opioid Topical Pain Relief Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Non-opioid Topical Pain Relief Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Non-opioid Topical Pain Relief Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Non-opioid Topical Pain Relief Market Share by Country (2021-2026) Table 184. Latin America Non-opioid Topical Pain Relief Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Non-opioid Topical Pain Relief Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Non-opioid Topical Pain Relief Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Non-opioid Topical Pain Relief Sales by Country (2021-2026) & (k units) Table 188. Middle East and Africa Non-opioid Topical Pain Relief Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Non-opioid Topical Pain Relief Sales Forecast by Country (2027-2032) & (k units) Table 190. Middle East and Africa Non-opioid Topical Pain Relief Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Non-opioid Topical Pain Relief Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Non-opioid Topical Pain Relief Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Non-opioid Topical Pain Relief Market Share by Country (2021-2026) Table 194. Middle East and Africa Non-opioid Topical Pain Relief Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Non-opioid Topical Pain Relief Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Non-opioid Topical Pain Relief Distributors List Table 199. Non-opioid Topical Pain Relief Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Non-opioid Topical Pain Relief Image Figure 2. Global Non-opioid Topical Pain Relief Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-opioid Topical Pain Relief Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-opioid Topical Pain Relief Sales (2021-2032) & (k units) Figure 5. Prescription Pain Relief Image Figure 6. Global Prescription Pain Relief Sales YoY Growth (2021-2032) & (k units) Figure 7. Over-The-Counter Pain Relief Image Figure 8. Global Over-The-Counter Pain Relief Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Non-opioid Topical Pain Relief Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Non-opioid Topical Pain Relief Market Share by Type 2025 VS 2032 Figure 11. North America Non-opioid Topical Pain Relief Sales Market Share in Volume by Type in 2025 Figure 12. North America Non-opioid Topical Pain Relief Sales Market Share in Value by Type in 2025 Figure 13. Europe Non-opioid Topical Pain Relief Sales Market Share in Volume by Type in 2025 Figure 14. Europe Non-opioid Topical Pain Relief Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Non-opioid Topical Pain Relief Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Non-opioid Topical Pain Relief Sales Market Share in Value by Type in 2025 Figure 17. Latin America Non-opioid Topical Pain Relief Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Non-opioid Topical Pain Relief Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Non-opioid Topical Pain Relief Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Non-opioid Topical Pain Relief Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Non-opioid Topical Pain Relief Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Clinic Image Figure 24. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 27. Pharmacy Image Figure 28. Global Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Non-opioid Topical Pain Relief Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Non-opioid Topical Pain Relief Market Share by Application 2025 VS 2032 Figure 33. North America Non-opioid Topical Pain Relief Sales Market Share in Volume by Application in 2025 Figure 34. North America Non-opioid Topical Pain Relief Sales Market Share in Value by Application in 2025 Figure 35. Europe Non-opioid Topical Pain Relief Sales Market Share in Volume by Application in 2025 Figure 36. Europe Non-opioid Topical Pain Relief Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Non-opioid Topical Pain Relief Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Non-opioid Topical Pain Relief Sales Market Share in Value by Application in 2025 Figure 39. Latin America Non-opioid Topical Pain Relief Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Non-opioid Topical Pain Relief Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Non-opioid Topical Pain Relief Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Non-opioid Topical Pain Relief Sales Market Share in Value by Application in 2025 Figure 43. North America Non-opioid Topical Pain Relief Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Non-opioid Topical Pain Relief Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Non-opioid Topical Pain Relief Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Non-opioid Topical Pain Relief Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Non-opioid Topical Pain Relief Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Non-opioid Topical Pain Relief Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Non-opioid Topical Pain Relief Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Non-opioid Topical Pain Relief Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Non-opioid Topical Pain Relief Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Non-opioid Topical Pain Relief Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Non-opioid Topical Pain Relief Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Non-opioid Topical Pain Relief Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Non-opioid Topical Pain Relief Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Non-opioid Topical Pain Relief Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Non-opioid Topical Pain Relief Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Non-opioid Topical Pain Relief Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Non-opioid Topical Pain Relief Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Non-opioid Topical Pain Relief Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Non-opioid Topical Pain Relief Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Non-opioid Topical Pain Relief Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Non-opioid Topical Pain Relief Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Non-opioid Topical Pain Relief Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Pain Relief
  • Over-The-Counter Pain Relief
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Teva Pharmaceutical
  • Sanofi
  • Johnson and Johnson
  • Mylan
  • Pfizer
  • GlaxoSmithKline
  • Topical BioMedics
  • Tibet Cheezheng Tibetan Medicine
  • Sun Pharmaceutical Industries
  • Reckitt Benckiser Group
  • Lingrui Pharmaceutical
  • Hisamitsu
  • China Resources Sanjiu Medical & Pharmaceutical
  • AdvaCare Pharma
  • Abacus Health Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-opioid Topical Pain Relief Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Non-opioid Topical Pain Relief Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Non-opioid Topical Pain Relief Market by Type
  6. 1.3.1 Prescription Pain Relief
  7. 1.3.2 Over-The-Counter Pain Relief
  8. 1.4 Global Non-opioid Topical Pain Relief Market Size by Type
  9. 1.4.1 Global Non-opioid Topical Pain Relief Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Non-opioid Topical Pain Relief Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Non-opioid Topical Pain Relief Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Non-opioid Topical Pain Relief Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Non-opioid Topical Pain Relief Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Non-opioid Topical Pain Relief Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Non-opioid Topical Pain Relief Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Non-opioid Topical Pain Relief Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Non-opioid Topical Pain Relief Industry Trends
  2. 2.2 Non-opioid Topical Pain Relief Industry Drivers
  3. 2.3 Non-opioid Topical Pain Relief Industry Opportunities and Challenges
  4. 2.4 Non-opioid Topical Pain Relief Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Non-opioid Topical Pain Relief Revenue (2021-2026)
  2. 3.2 Global Top Players by Non-opioid Topical Pain Relief Sales (2021-2026)
  3. 3.3 Global Top Players by Non-opioid Topical Pain Relief Price (2021-2026)
  4. 3.4 Global Non-opioid Topical Pain Relief Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-opioid Topical Pain Relief Major Company Production Sites & Headquarters
  6. 3.6 Global Non-opioid Topical Pain Relief Company, Product Type & Application
  7. 3.7 Global Non-opioid Topical Pain Relief Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-opioid Topical Pain Relief Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-opioid Topical Pain Relief Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-opioid Topical Pain Relief Tier 1, Tier 2, and Tier 3
4 Non-opioid Topical Pain Relief Regional Status and Outlook
  1. 4.1 Global Non-opioid Topical Pain Relief Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Non-opioid Topical Pain Relief Historic Market Size by Region
  3. 4.2.1 Global Non-opioid Topical Pain Relief Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Non-opioid Topical Pain Relief Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Non-opioid Topical Pain Relief Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Non-opioid Topical Pain Relief Forecasted Market Size by Region
  7. 4.3.1 Global Non-opioid Topical Pain Relief Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Non-opioid Topical Pain Relief Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Non-opioid Topical Pain Relief Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Non-opioid Topical Pain Relief by Application
  1. 5.1 Non-opioid Topical Pain Relief Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Non-opioid Topical Pain Relief Market Size by Application
  7. 5.2.1 Global Non-opioid Topical Pain Relief Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Non-opioid Topical Pain Relief Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Non-opioid Topical Pain Relief Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Non-opioid Topical Pain Relief Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Non-opioid Topical Pain Relief Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Non-opioid Topical Pain Relief Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Non-opioid Topical Pain Relief Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Non-opioid Topical Pain Relief Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical
  2. 6.1.1 Teva Pharmaceutical Company Information
  3. 6.1.2 Teva Pharmaceutical Business Overview
  4. 6.1.3 Teva Pharmaceutical Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Non-opioid Topical Pain Relief Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson and Johnson
  14. 6.3.1 Johnson and Johnson Company Information
  15. 6.3.2 Johnson and Johnson Business Overview
  16. 6.3.3 Johnson and Johnson Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson and Johnson Non-opioid Topical Pain Relief Product Portfolio
  18. 6.3.5 Johnson and Johnson Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Non-opioid Topical Pain Relief Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Non-opioid Topical Pain Relief Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Non-opioid Topical Pain Relief Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 Topical BioMedics
  38. 6.7.1 Topical BioMedics Company Information
  39. 6.7.2 Topical BioMedics Business Overview
  40. 6.7.3 Topical BioMedics Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Topical BioMedics Non-opioid Topical Pain Relief Product Portfolio
  42. 6.7.5 Topical BioMedics Recent Developments
  43. 6.8 Tibet Cheezheng Tibetan Medicine
  44. 6.8.1 Tibet Cheezheng Tibetan Medicine Company Information
  45. 6.8.2 Tibet Cheezheng Tibetan Medicine Business Overview
  46. 6.8.3 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product Portfolio
  48. 6.8.5 Tibet Cheezheng Tibetan Medicine Recent Developments
  49. 6.9 Sun Pharmaceutical Industries
  50. 6.9.1 Sun Pharmaceutical Industries Company Information
  51. 6.9.2 Sun Pharmaceutical Industries Business Overview
  52. 6.9.3 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product Portfolio
  54. 6.9.5 Sun Pharmaceutical Industries Recent Developments
  55. 6.10 Reckitt Benckiser Group
  56. 6.10.1 Reckitt Benckiser Group Company Information
  57. 6.10.2 Reckitt Benckiser Group Business Overview
  58. 6.10.3 Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Reckitt Benckiser Group Non-opioid Topical Pain Relief Product Portfolio
  60. 6.10.5 Reckitt Benckiser Group Recent Developments
  61. 6.11 Lingrui Pharmaceutical
  62. 6.11.1 Lingrui Pharmaceutical Company Information
  63. 6.11.2 Lingrui Pharmaceutical Business Overview
  64. 6.11.3 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio
  66. 6.11.5 Lingrui Pharmaceutical Recent Developments
  67. 6.12 Hisamitsu
  68. 6.12.1 Hisamitsu Company Information
  69. 6.12.2 Hisamitsu Business Overview
  70. 6.12.3 Hisamitsu Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hisamitsu Non-opioid Topical Pain Relief Product Portfolio
  72. 6.12.5 Hisamitsu Recent Developments
  73. 6.13 China Resources Sanjiu Medical & Pharmaceutical
  74. 6.13.1 China Resources Sanjiu Medical & Pharmaceutical Company Information
  75. 6.13.2 China Resources Sanjiu Medical & Pharmaceutical Business Overview
  76. 6.13.3 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio
  78. 6.13.5 China Resources Sanjiu Medical & Pharmaceutical Recent Developments
  79. 6.14 AdvaCare Pharma
  80. 6.14.1 AdvaCare Pharma Company Information
  81. 6.14.2 AdvaCare Pharma Business Overview
  82. 6.14.3 AdvaCare Pharma Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 AdvaCare Pharma Non-opioid Topical Pain Relief Product Portfolio
  84. 6.14.5 AdvaCare Pharma Recent Developments
  85. 6.15 Abacus Health Products
  86. 6.15.1 Abacus Health Products Company Information
  87. 6.15.2 Abacus Health Products Business Overview
  88. 6.15.3 Abacus Health Products Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Abacus Health Products Non-opioid Topical Pain Relief Product Portfolio
  90. 6.15.5 Abacus Health Products Recent Developments
7 North America by Country
  1. 7.1 North America Non-opioid Topical Pain Relief Sales by Country
  2. 7.1.1 North America Non-opioid Topical Pain Relief Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Non-opioid Topical Pain Relief Sales by Country (2021-2026)
  4. 7.1.3 North America Non-opioid Topical Pain Relief Sales Forecast by Country (2027-2032)
  5. 7.2 North America Non-opioid Topical Pain Relief Market Size by Country
  6. 7.2.1 North America Non-opioid Topical Pain Relief Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Non-opioid Topical Pain Relief Market Size by Country (2021-2026)
  8. 7.2.3 North America Non-opioid Topical Pain Relief Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Non-opioid Topical Pain Relief Sales by Country
  2. 8.1.1 Europe Non-opioid Topical Pain Relief Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Non-opioid Topical Pain Relief Sales by Country (2021-2026)
  4. 8.1.3 Europe Non-opioid Topical Pain Relief Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Non-opioid Topical Pain Relief Market Size by Country
  6. 8.2.1 Europe Non-opioid Topical Pain Relief Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Non-opioid Topical Pain Relief Market Size by Country (2021-2026)
  8. 8.2.3 Europe Non-opioid Topical Pain Relief Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Non-opioid Topical Pain Relief Sales by Country
  2. 9.1.1 Asia-Pacific Non-opioid Topical Pain Relief Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Non-opioid Topical Pain Relief Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Non-opioid Topical Pain Relief Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Non-opioid Topical Pain Relief Market Size by Country
  6. 9.2.1 Asia-Pacific Non-opioid Topical Pain Relief Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Non-opioid Topical Pain Relief Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Non-opioid Topical Pain Relief Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Non-opioid Topical Pain Relief Sales by Country
  2. 10.1.1 South America Non-opioid Topical Pain Relief Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Non-opioid Topical Pain Relief Sales by Country (2021-2026)
  4. 10.1.3 South America Non-opioid Topical Pain Relief Sales Forecast by Country (2027-2032)
  5. 10.2 South America Non-opioid Topical Pain Relief Market Size by Country
  6. 10.2.1 South America Non-opioid Topical Pain Relief Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Non-opioid Topical Pain Relief Market Size by Country (2021-2026)
  8. 10.2.3 South America Non-opioid Topical Pain Relief Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Non-opioid Topical Pain Relief Sales by Country
  2. 11.1.1 Middle East and Africa Non-opioid Topical Pain Relief Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Non-opioid Topical Pain Relief Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Non-opioid Topical Pain Relief Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Non-opioid Topical Pain Relief Market Size by Country
  6. 11.2.1 Middle East and Africa Non-opioid Topical Pain Relief Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Non-opioid Topical Pain Relief Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Non-opioid Topical Pain Relief Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Non-opioid Topical Pain Relief Value Chain Analysis
  2. 12.1.1 Non-opioid Topical Pain Relief Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Non-opioid Topical Pain Relief Production Mode & Process
  7. 12.2 Non-opioid Topical Pain Relief Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Non-opioid Topical Pain Relief Distributors
  10. 12.2.3 Non-opioid Topical Pain Relief Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst